Novo Nordisk A/S (CPH: NOVO-B) is being punished this morning after posting a disappointing update related to CagriSema. The pharmaceutical behemoth said its experimental weight-loss treatment helped patients lower their weight by 22.7% in a late-stage trial – lower than 25% it had originally expected. Novo Nordisk stock was down…
Shares of Humacyte Inc (NASDAQ: HUMA) nearly doubled on Friday after receiving full approval for its flagship SYMVESS product…
This week, the LATAM cryptocurrency landscape demonstrated its dynamic nature once more. El Salvador has decided to continue with…
The latest economic data reveals a welcome moderation in inflation, as the personal consumption expenditures (PCE) price index rose…
Southeast Asia, a region of over 675 million people, is emerging as a focal point for global investment in…
Thwarted expectations of up to 4 rate cuts in 2025 have sent US stocks tumbling down in recent days.…
Investors are bailing on Micron Technology Inc (NASDAQ: MU) this morning after the chipmaker issued guidance for its current…
The United Nations reported on Wednesday that the economies of Latin America and the Caribbean are expected to rise…
Bank of America Securities recently warned that Advanced Micro Devices Inc (NASDAQ: AMD) could find it incrementally difficult to…